HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Majid Naderi Selected Research

Hemorrhagic Disorders (Hemorrhagic Diathesis)

2/2019A Unique Factor XIII Mutation in Southeastern Iran with an Unexpectedly High Prevalence: Khash Factor XIII.
11/2014Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Majid Naderi Research Topics

Disease

13Hemorrhage
07/2021 - 04/2014
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2018 - 01/2014
4Intracranial Hemorrhages (Intracranial Hemorrhage)
07/2021 - 04/2014
3beta-Thalassemia (Cooley's Anemia)
02/2021 - 11/2013
3Factor XIII Deficiency
12/2016 - 09/2015
3Thalassemia
10/2016 - 11/2013
2Wounds and Injuries (Trauma)
12/2019 - 12/2016
2Hemorrhagic Disorders (Hemorrhagic Diathesis)
02/2019 - 11/2014
2Neoplasms (Cancer)
10/2017 - 12/2012
2Hepatitis
10/2016 - 03/2016
2Spontaneous Abortion (Miscarriage)
06/2016 - 11/2014
1Hemolytic Anemia
02/2021
1Postpartum Hemorrhage
01/2021
1Rare Diseases (Rare Disease)
01/2020
1Gaucher Disease (Gaucher's Disease)
01/2020
1Thrombasthenia (Glanzmann Thrombasthenia)
01/2018
1Vomiting
01/2018
1Headache (Headaches)
01/2018
1Disseminated Intravascular Coagulation
12/2016
1Diabetes Mellitus
10/2016
1Habitual Abortion (Recurrent Miscarriage)
06/2016
1Hemophilia A (Haemophilia)
01/2016
1Vision Disorders (Hemeralopia)
04/2014
1Mental Disorders (Mental Disorder)
04/2014
1Hematologic Neoplasms (Hematological Malignancy)
01/2014
1Anemia
11/2013
1Iron Overload
11/2013
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
12/2012

Drug/Important Bio-Agent (IBA)

13Factor XIII (Coagulation Factor XIII)IBA
07/2021 - 04/2014
3FibrinolysinFDA Link
01/2016 - 04/2014
2DNA (Deoxyribonucleic Acid)IBA
10/2017 - 01/2016
2MicroRNAs (MicroRNA)IBA
10/2014 - 01/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2021
1Blood Group Antigens (Blood Groups)IBA
02/2021
1Biosimilar PharmaceuticalsIBA
01/2020
1Factor XI (Plasma Thromboplastin Antecedent)IBA
12/2019
1Long Noncoding RNAIBA
02/2018
1Antisense RNA (Anti-Sense RNA)IBA
02/2018
1Factor VII (Proconvertin)IBA
01/2018
1Histidine (L-Histidine)FDA Link
10/2017
1Messenger RNA (mRNA)IBA
10/2017
1Dacarbazine (DIC)FDA LinkGeneric
12/2016
1fibrin fragment D (D-dimer)IBA
12/2016
1Chelating AgentsIBA
10/2016
1IronIBA
10/2016
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
07/2016
1Factor V (Coagulation Factor V)IBA
06/2016
1GlobinsIBA
06/2016
1Ferritins (Ferritin)IBA
03/2016
1Factor VIIa (Activated Factor VII)IBA
01/2016
1anti-inhibitor coagulant complexIBA
01/2016
1recombinant FVIIa (rFVIIa)FDA Link
01/2016
1prothrombin complex concentrates (PPSB)IBA
01/2016
1Matrix Metalloproteinases (MMPs)IBA
09/2015
1Plasminogen Activators (Plasminogen Activator)IBA
03/2015
1Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
03/2015
1Blood Coagulation Factors (Coagulation Factor)IBA
01/2015
13' Untranslated Regions (3' UTR)IBA
10/2014
1OsteoprotegerinIBA
10/2014
1human MIRN499 microRNAIBA
01/2014
1DeferasiroxFDA Link
11/2013

Therapy/Procedure

4Therapeutics
01/2018 - 09/2015
2Blood Transfusion (Blood Transfusions)
02/2021 - 10/2016
1Splenectomy
03/2016
1Chelation Therapy (Therapy, Chelation)
11/2013
1Aftercare (After-Treatment)
12/2012